Inhibition of the IL-17A axis Protects against Immune-related Adverse Events while Supporting Checkpoint Inhibitor Anti-tumor Efficacy

Melissa G. Lechner(University of California, Los Angeles), Maureen A. Su(University of California, Los Angeles)
bioRxiv (Cold Spring Harbor Laboratory)
January 21, 2022
Cited by 2


Related Papers